[go: up one dir, main page]

WO2006101909A3 - Polytherapies pour le traitement ou la prevention de maladies - Google Patents

Polytherapies pour le traitement ou la prevention de maladies Download PDF

Info

Publication number
WO2006101909A3
WO2006101909A3 PCT/US2006/009359 US2006009359W WO2006101909A3 WO 2006101909 A3 WO2006101909 A3 WO 2006101909A3 US 2006009359 W US2006009359 W US 2006009359W WO 2006101909 A3 WO2006101909 A3 WO 2006101909A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
preventing diseases
combination therapy
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/009359
Other languages
English (en)
Other versions
WO2006101909A2 (fr
Inventor
Steven A Kates
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISCHEMIX Inc
Original Assignee
ISCHEMIX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISCHEMIX Inc filed Critical ISCHEMIX Inc
Publication of WO2006101909A2 publication Critical patent/WO2006101909A2/fr
Publication of WO2006101909A3 publication Critical patent/WO2006101909A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions utilisées pour traiter au prévenir des maladies ou des états pathologiques, notamment, l'ischémie. Ces compositions contiennent une dose thérapeutiquement efficace d'un composé peptidique associé au DMSO. Par ailleurs, l'invention concerne des procédés d'administration de ces compositions pour traiter au prévenir l'ischémie, ainsi que des procédés de préparation de ces compositions.
PCT/US2006/009359 2005-03-16 2006-03-14 Polytherapies pour le traitement ou la prevention de maladies Ceased WO2006101909A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66219605P 2005-03-16 2005-03-16
US60/662,196 2005-03-16

Publications (2)

Publication Number Publication Date
WO2006101909A2 WO2006101909A2 (fr) 2006-09-28
WO2006101909A3 true WO2006101909A3 (fr) 2006-12-21

Family

ID=37024361

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/009359 Ceased WO2006101909A2 (fr) 2005-03-16 2006-03-14 Polytherapies pour le traitement ou la prevention de maladies

Country Status (1)

Country Link
WO (1) WO2006101909A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890896B1 (en) 1999-11-18 2005-05-10 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
US8507439B2 (en) 2005-08-29 2013-08-13 Angela Shashoua Neuroprotective and neurorestorative method and compositions
US7928067B2 (en) 2009-05-14 2011-04-19 Ischemix Llc Compositions and methods for treating ischemia and ischemia-reperfusion injury
WO2012067947A1 (fr) 2010-11-18 2012-05-24 Ischemix Llc Composés lipoylés et leur utilisation pour le traitement d'une lésion ischémique
EP4282411A1 (fr) 2017-04-25 2023-11-29 Ischemix LLC Lipoyl-glu-ala pour son utilisation dans le traitement des lésions dégénératives
CN112584866A (zh) * 2018-07-20 2021-03-30 北京蔚蓝之源医药科技有限公司 亚砜类化合物在预防放射性口腔黏膜炎及相关放疗并发症中的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092781A2 (fr) * 2001-05-17 2002-11-21 Ceremedix, Inc. Composes de peptides contrecarrant lessubstances oxygenees et les radicaux libres
US6562345B1 (en) * 1996-11-12 2003-05-13 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562345B1 (en) * 1996-11-12 2003-05-13 City Of Hope Immuno-reactive peptide CTL epitopes of human cytomegalovirus
WO2002092781A2 (fr) * 2001-05-17 2002-11-21 Ceremedix, Inc. Composes de peptides contrecarrant lessubstances oxygenees et les radicaux libres

Also Published As

Publication number Publication date
WO2006101909A2 (fr) 2006-09-28

Similar Documents

Publication Publication Date Title
WO2008048589A3 (fr) Composés et procédés pour le traitement du virus de l'hépatite c
WO2008097640A3 (fr) Composés à base de triazole modulant l'activité de hsp90
MX2007009649A (es) Derivados de meleimida, composiciones farmaceuticas y metodos para el tratamiento del cancer.
WO2006096439A3 (fr) Compositions pharmaceutiques destinees au traitement et/ou a la prevention de la schizophrenie et de maladies associees
WO2009129246A3 (fr) Compositions et leurs procédés de préparation et d'utilisation
WO2010017545A3 (fr) Composés de triazole qui modulent l'activité hsp90
WO2008124085A3 (fr) Méthodes d'utilisation de combinaisons d'inhibiteurs de mek et de jak-2
WO2007139967A3 (fr) Composés de triazole modulant l'activité de hsp90
WO2007139955A8 (fr) Composés de triazole qui modulent l'activité de la hsp90
WO2007094819A3 (fr) Dérivés de triazole modulant l'activité de hsp90
WO2007139968A3 (fr) Composés de triazole qui modulent l'activité de la hsp90
WO2006044775A3 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
WO2008148074A3 (fr) Inhibiteurs de mtor et methodes de traitement mettant en œuvre ces inhibiteurs
MX2007005590A (es) Compuestos del inhibidor glicogeno fosforilasa y sus composiciones farmaceuticas.
WO2009002808A3 (fr) Composés de quinazolinone et leurs méthodes d'utilisation
EP3276004A3 (fr) Procédés de traitement d'une maladie rénale chronique
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
WO2006124012A3 (fr) Composes pour le traitement de la maladie d'alzheimer et pour l'inhibition de la production du peptide amyloide beta
WO2007005300A3 (fr) Traitement de la keratoconjonctivite seche
WO2007009120A3 (fr) Composes et compositions utilises comme mimetiques de la tpo
WO2007022408A3 (fr) Methodes de traitement du cancer combinant saha et targretin
WO2008103378A3 (fr) Méthodes de traitement de la sclérose en plaques par administration d'une alpha-foetoprotéine combinée à un antagoniste de l'intégrine
WO2007019153A3 (fr) Methodes de traitement de l'hypertension
WO2007022269A3 (fr) Composés et compositions en tant que mimétiques de tpo
WO2005121778A3 (fr) Procedes d'identification, et composes utiles pour le traitement de maladies degeneratives et inflammatoires

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06738422

Country of ref document: EP

Kind code of ref document: A2